RXRX (Recursion Corp) Forward P/S Multiple

Corporate emblem and logo of Recursion Pharmaceuticals (RXRX)

Recursion Pharmaceuticals (RXRX) generates revenue through licenses and payments from pharmaceutical leaders for AI-driven molecule discovery while optimizing supercomputer energy costs. The company's forward P/S on GURU.Markets reflects market expectations, where 27.20 is recorded as the baseline value. Business development relies on alliances with GPU manufacturers for accelerated data analysis, transforming modern medicine.

Recursion Pharmaceuticals, Inc. - RXRX Forward P/S Multiple (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Recursion Corp (RXRX)

- market price and analyst price targets:
Price Chart Recursion Pharmaceuticals Inc|RXRX - Forecast Levels Chart
- business market valuation indicators:
Market Capitalization Recursion Corp|RXRX - Value Adjusted for Debt and Cash
- issuer book value statistics:
Book Value per Share Recursion|RXRX - Book Capitalization|Market Value to Book Value Ratio recursion.com|RXRX - Aggregate Asset Value
- debt and solvency information:
Debt to Equity Recursion Pharmaceuticals|RXRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Recursion Pharmaceuticals|RXRX - Company Aggregate Debts|Debts to Book Capitalization Recursion Corp|RXRX - Company Long-Term Liabilities|Company Short-Term Debts Recursion|Quick Liquidity Indicator recursion.com
- financial results and valuation multiples details:
RXRX - Net Profit|Future Profit Recursion Pharmaceuticals|RXRX - Market Price to Net Income Ratio|Forward P/E Multiple Recursion Pharmaceuticals, Inc.|RXRX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Recursion Corp|RXRX - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Recursion|RXRX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months recursion.com|RXRX - Earnings per share growth in current year|Net earnings per share growth forecast for next year Recursion Pharmaceuticals
- total revenue and sales volume data:
RXRX - Company Gross Revenue|Company Projected Revenue Recursion Corp|RXRX - Market Capitalization-to-Revenue Ratio|Forward Price-to-Revenue Multiple Recursion Corp
Fundamental company analysis:Recursion RXRX
Original product of Recursion Corp

This metric reflects the market value of the business relative to expected revenue, allowing investors to assess the extent of an asset's premium or discount during a sharp revision of trading expectations. Analyzing the future P/S ratio for Recursion Pharmaceuticals (RXRX) is critical, as valuation volatility here depends directly on market confidence in the success of the AI platform and automated laboratories transforming traditional drug discovery.

Competitors of Recursion Pharmaceuticals (RXRX)

Price-to-Projected Revenue Ratio NVIDIA NVDA|CRWV (CoreWeave, Inc.) - Future Price to Revenue|Nebius AI - Forward P/S Multiple|Forward Price to Sales SOUN (SoundHound Corp)|ZETA: Forward P/S Multiple|pagaya.com (PGY) - Forward P/S Multiple|Price-to-Projected Revenue Ratio C3 AI|RZLV: Forward Price to Sales|Price-to-Projected Revenue Ratio Super X AI Corp (SUPX)|Forward Price-to-Revenue Multiple Ginkgo Bioworks Corp. DNA|Forward P/S Multiple CRNC (Cerence Inc.)|Forward P/S Multiple palladyneai.com PDYN|Veritone Corp - Forward P/S Multiple|Mint Incorporation (MIMI) - Forward Price-to-Revenue Multiple|MLGO: Forward P/S Multiple|Market Cap to Future Revenue Ratio Helport AI (HPAI)|Forward Price-to-Revenue Multiple LPSN|Forward P/S Multiple QuickLogic Corp.|Forward Price-to-Revenue Multiple SST (System1, Inc.)|Price to Expected Revenue Ratio DVLT|Forward P/S Multiple RYET (Ruanyun Edai Tech)|Market Cap to Expected Sales Ratio Wetour (WETO)|Micropolis Holding - Forward P/S Multiple|Cyngn Inc. (CYN) - Forward Price-to-Revenue Multiple|YYAI: Forward P/S Multiple|MicroCloud Hologram Inc. (HOLO) - Forward P/S Multiple|Price-to-Projected Revenue Ratio MultiSensor AI Holdings|Price-to-Projected Revenue Ratio EVAX|Price-to-Projected Revenue Ratio Xiao-I (AIXI)|Market Cap to Expected Sales Ratio cxapp.com|Price-to-Projected Revenue Ratio Brand Engagement Network Inc. BNAI|Forward Price to Sales GXAI|EVGN: Forward Price-to-Revenue Multiple|IFBD (Infobird Co., Ltd) - Market Cap to Projected Revenue|Taoping Inc. (TAOP) - Price-to-Projected Revenue Ratio|VERSES AI - Forward Price to Sales|Forward Price-to-Revenue Multiple EXAI|Market Cap to Projected Revenue FOXO (foxotechnologies.com)|Forward P/S Multiple VHAI|Forward P/S Multiple zapata.ai (ZPTA)